Literature DB >> 1717219

PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

M Koltai1, D Hosford, P Guinot, A Esanu, P Braquet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1717219     DOI： 10.2165/00003495-199142020-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  345 in total

1.  PAF-acether modifies human peritoneal macrophage cAMP levels in a biphasic fashion.

Authors:  M J Adolfs; F D Beusenberg; I L Bonta
Journal:  Agents Actions       Date:  1989-01

Review 2.  Acute and long-term pulmonary effects of platelet-activating factor.

Authors:  J M Mencia-Huerta; D Hosford; P Braquet
Journal:  Clin Exp Allergy       Date:  1989-03       Impact factor: 5.018

3.  Decreased sensitivity of platelets to platelet-activating factor in migraine patients during the headache-free interval.

Authors:  F Hermán; K Magyar; K Kovács; J Filep
Journal:  Thromb Haemost       Date:  1989-09-29       Impact factor: 5.249

4.  Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis.

Authors:  J P Cueva; W Hsueh
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

5.  Antigen-induced bronchopulmonary alterations in the guinea pig: a new model of passive sensitization mediated by mouse IgE antibodies.

Authors:  S Desquand; J Lefort; F T Liu; J M Mencia-Huerta; B B Vargaftig
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

6.  Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.

Authors:  R Rabinovici; T L Yue; M Farhat; E F Smith; K M Esser; M Slivjak; G Feuerstein
Journal:  J Pharmacol Exp Ther       Date:  1990-10       Impact factor: 4.030

7.  Paf-induced release of spasmogens from guinea-pig lungs.

Authors:  S Jancar; P Thériault; M Lauzière; P Braquet; P Sirois
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

Review 8.  Platelet-activating factor: a paracrine factor in preimplantation stages of reproduction?

Authors:  M J Harper
Journal:  Biol Reprod       Date:  1989-05       Impact factor: 4.285

9.  Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo.

Authors:  T L Yue; R Rabinovici; M Farhat; G Feuerstein
Journal:  J Lipid Mediat       Date:  1991 Jan-Feb

10.  Platelet-activating factor and serum components from oestrous mice co-operate to mimic the activity of 'early pregnancy factor' in the rosette inhibition assay.

Authors:  C Orozco; I Cock; A V Perkins; F M Clarke
Journal:  J Reprod Fertil       Date:  1990-03
View more
  19 in total

Review 1.  Treatment of bronchospastic disorders in the 1990s. What does the future hold?

Authors:  P G Gianaris; J A Golish
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

2.  Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy.

Authors:  Alberto E Musto; Mark Samii
Journal:  Epilepsia       Date:  2011-01-04       Impact factor: 5.864

3.  Isolation and structural elucidation of biologically active phospholipids from Scytonema julianum (cyanobacteria).

Authors:  Smaragdi Antonopoulou; Alexandra Oikonomou; Haralabos C Karantonis; Elizabeth Fragopoulou; Adriani Pantazidou
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

Review 4.  Structural and (patho)physiological diversity of PAF.

Authors:  R N Pinckard; D S Woodard; H J Showell; M J Conklyn; M J Novak; L M McManus
Journal:  Clin Rev Allergy       Date:  1994

Review 5.  Platelet-activating factor antagonists.

Authors:  M Koltai; P G Braquet
Journal:  Clin Rev Allergy       Date:  1994

6.  Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.

Authors:  R Caballero; C Valenzuela; M Longobardo; J Tamargo; E Delpón
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

7.  Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade.

Authors:  T Foitzik; H G Hotz; G Eibl; B Hotz; M Kirchengast; H J Buhr
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

8.  Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.

Authors:  M Giral; D Balsa; R Ferrando; M Merlos; J Garcia-Rafanell; J Forn
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor.

Authors:  Alexandros B Tsoupras; Maria Roulia; Eleftherios Ferentinos; Ioannis Stamatopoulos; Constantinos A Demopoulos; Panayotis Kyritsis
Journal:  Bioinorg Chem Appl       Date:  2010-06-28       Impact factor: 7.778

Review 10.  The pathophysiological role and therapeutic implications of platelet activating factor in diseases of aging.

Authors:  C Kroegel; C Kortsik; N Kroegel; H Matthys
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.